Share this video  

ESMO Breast 2020 | CORALLEEN: kicking chemo?

Aleix Prat, MD, PhD, Clinical and Provincial Hospital of Barcelona, Barcelona, Spain, discusses the CORALLEEN trial (NCT03248427), which investigated neadjuvant multi-agent chemotherapy or letrozole plus ribociclib in luminal B/HER2-negative breast cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).